0001437749-23-018537.txt : 20230626
0001437749-23-018537.hdr.sgml : 20230626
20230626183519
ACCESSION NUMBER: 0001437749-23-018537
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230620
FILED AS OF DATE: 20230626
DATE AS OF CHANGE: 20230626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eade Katherine A.
CENTRAL INDEX KEY: 0001721318
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41058
FILM NUMBER: 231043614
MAIL ADDRESS:
STREET 1: C/O HARVARD BIOSCIENCE, INC.
STREET 2: 84 OCTOBER HILL ROAD #10
CITY: HOLLISTON
STATE: MA
ZIP: 01746
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxxinity, Inc.
CENTRAL INDEX KEY: 0001851657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 862083865
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 ODYSSEY WAY
CITY: EXPLORATION PARK
STATE: FL
ZIP: 32953
BUSINESS PHONE: (254) 244-5739
MAIL ADDRESS:
STREET 1: 505 ODYSSEY WAY
CITY: EXPLORATION PARK
STATE: FL
ZIP: 32953
4
1
rdgdoc.xml
FORM 4
X0407
4
2023-06-20
0001851657
Vaxxinity, Inc.
VAXX
0001721318
Eade Katherine A.
505 ODYSSEY WAY
MERRITT ISLAND
FL
32953
1
0
Stock option (right to buy)
2.21
2023-06-20
4
A
0
132352
0
A
Class A common stock
132352
132352
D
These options were automatically granted following the Issuer's annual shareholders meeting pursuant to a policy adopted by the Issuer's board of directors providing for annual non-employee director compensation.
These options vest on the earliest of (i) the one-year anniversary of the grant date, (ii) the following year's annual stockholder meeting, and (iii) a Change in Control (as defined in the Vaxxinity, Inc. 2021 Omnibus Incentive Compensation Plan), in each case, subject to the Reporting Person's continued service with the Issuer through the vesting date.
These stock options shall expire upon the earlier of (i) the tenth anniversary of the grant date, and (ii) three months after the date the Reporting Person ceases to be a director, officer, employee or consultant of the Issuer or one of its affiliates.
/s/ Rene Paula Molina, attorney-in-fact for Katherine Eade
2023-06-26